Skip to content
RDL
Network
Ekosistem
Uygulama değiştir
EN
Hakkımızda
SSS
Giriş yap
Başla
Treatment of relapsed and refractory multiple myeloma in the era of novel agents — Niels W.C.J. van de Donk (2010) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Treatment of relapsed and refractory multiple myeloma in the era of novel agents
Shared by
Meletios A Dimopoulos
Treatment of relapsed and refractory multiple myeloma in the era of novel agents
Article
2010
en
Authors
+13 more
ND
Niels W.C.J. van de Donk
HL
Henk M. Lokhorst
Meletios A Dimopoulos
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Article
2009
Multiple Myeloma in the Era of Novel Agents
Meletios A Dimopoulos
,
Michel Attal
Article
2009
Treatment of Relapsed/Refractory Multiple Myeloma
Efstathios Kastritis
,
Antonio Palumbo
,
Meletios A Dimopoulos
Article
2015
Treatment options for relapsed and refractory multiple myeloma
Ajay K. Nooka
,
Efstathios Kastritis
,
Meletios A Dimopoulos
,
Sagar Lonial
Article
2015
Panobinostat: a novel pan-deacetylase inhibitor for the treatment of relapsed or relapsed and refractory multiple myeloma
Paul G. Richardson
,
Jacob P. Laubach
,
Sagar Lonial
,
Philippe Moreau
,
Sung‐Soo Yoon
,
Vânia TM Hungria
,
Meletios A Dimopoulos
,
Meral Beksaç
,
Melissa Alsina
,
Jesús F. San Miguel
Chapter in a book
2017
Treatment of Relapsed/Refractory Patients with Multiple Myeloma
Jacob P. Laubach
,
Philippe Moreau
,
Meletios A Dimopoulos
,
Paul G. Richardson
Discussion(0)
No comments yet. Be the first to comment.